Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M3,971Revenue (TTM) $M15.0Net Margin (%)-713.3Altman Z-Score51.1
Enterprise Value $M3,590EPS (TTM) $-1.2Operating Margin %-751.8Piotroski F-Score2
P/E(ttm)--Beneish M-Score-4.4Pre-tax Margin (%)-713.3Higher ROA y-yN
Price/Book9.610-y EBITDA Growth Rate %--Quick Ratio17.2Cash flow > EarningsY
Price/Sales2655-y EBITDA Growth Rate %--Current Ratio17.2Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-21.7Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-23.9Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M86.7ROIC % (ttm)-164.0Gross Margin Increase y-yN

Gurus Latest Trades with NBIX

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
NBIXGeorge Soros 2016-03-31 Buy 0.01%$32.19 - $56.57
($40.01)
$ 45.8315%New holding9,400
NBIXGeorge Soros 2013-09-30 Sold Out -0.03%$10.6 - $16.7
($13.79)
$ 45.83232%Sold Out0
NBIXGeorge Soros 2013-06-30 Buy 0.03%$10.9 - $13.57
($12.28)
$ 45.83273%New holding200,000
NBIXJoel Greenblatt 2012-12-31 Sold Out -0.13%$6.88 - $8.66
($7.6)
$ 45.83503%Sold Out0
NBIXJoel Greenblatt 2012-06-30 Add0.03%$6.31 - $8.06
($7.18)
$ 45.83538%Add 23.80%259,903
NBIXGeorge Soros 2012-06-30 Sold Out -0.02%$6.31 - $8.06
($7.18)
$ 45.83538%Sold Out0
NBIXJoel Greenblatt 2012-03-31 Buy 0.15%$7.33 - $9.79
($7.95)
$ 45.83476%New holding209,930
NBIXGeorge Soros 2012-03-31 Buy 0.02%$7.33 - $9.79
($7.95)
$ 45.83476%New holding150,000
NBIXGeorge Soros 2011-12-31 Sold Out -0.0018%$5.5 - $8.58
($6.76)
$ 45.83578%Sold Out0
NBIXGeorge Soros 2011-09-30 Reduce$5.59 - $8.44
($6.71)
$ 45.83583%Reduce -23.93%17,800
NBIXGeorge Soros 2011-06-30 Add$6.82 - $8.3
($7.54)
$ 45.83508%Add 90.24%23,400
NBIXGeorge Soros 2011-03-31 Add$6.47 - $7.84
($7.2)
$ 45.83537%Add 23.00%12,300
NBIXGeorge Soros 2010-12-31 Buy $5.99 - $8.53
($7.63)
$ 45.83501%New holding10,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

NBIX is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


NBIX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
POPS RICHARD FDirector 2016-05-25Sell15,000$46.72-1.9view
OBrien Christopher FlintChief Medical Officer 2016-05-16Sell25,000$451.84view
Gano KyleChief Business Development Off 2016-04-11Sell41,770$44.024.11view
OBrien Christopher FlintChief Medical Officer 2016-04-06Sell25,000$451.84view
OBrien Christopher FlintChief Medical Officer 2016-02-03Sell1,500$38.0120.57view
Grigoriadis Dimitri E.Chief Research Officer 2016-02-03Sell1,375$37.9820.67view
GORMAN KEVIN CHARLESPresident and CEO 2016-02-03Sell3,125$38.0420.48view
Gano KyleChief Business Development Off 2016-02-03Sell1,375$37.9820.67view
Coughlin Timothy PCFO 2016-02-03Sell1,500$38.0620.42view
Bozigian Haig P.Chief Development Officer 2016-02-03Sell1,375$38.1320.19view

Quarterly/Annual Reports about NBIX:

News about NBIX:

Articles On GuruFocus.com
Meridian Funds Comments on Neurocrine Biosciences Aug 31 2015 
Meridian Contrarian Fund Annual Report 2015 Aug 31 2015 
Weekly Insider Sells Highlight: ORCL, TWC, FB, NBIX Jan 13 2014 
5 Strong Healthcare Stocks For 2012 Mar 24 2012 
Consider These 5 Healthcare Stocks Now Mar 21 2012 
Neurocrine Biosciences Inc. (NBIX) VP and CFO Timothy P Coughlin sells 12,320 Shares Mar 02 2011 
Neurocrine Biosciences Inc. (NBIX) President and CEO Kevin Charles Gorman sells 15,400 Shares Mar 02 2011 
Neurocrine Biosciences Inc. Reports Operating Results (10-Q) Oct 29 2010 
Neurocrine Biosciences Inc. Reports Operating Results (10-Q) Jul 29 2010 
Neurocrine Biosciences Inc. Reports Operating Results (10-Q) Apr 29 2010 

More From Other Websites
NEUROCRINE BIOSCIENCES INC Files SEC form 8-K, Change in Directors or Principal Officers, Amendments... May 24 2016
Neurocrine Biosciences Announces the Retirement of W. Thomas Mitchell from the Board of Directors May 20 2016
Neurocrine Biosciences Announces the Retirement of W. Thomas Mitchell from the Board of Directors May 20 2016
ETF’s with exposure to Neurocrine Biosciences, Inc. : May 19, 2016 May 19 2016
NEUROCRINE BIOSCIENCES INC Financials May 12 2016
Neurocrine Biosciences, Inc. :NBIX-US: Earnings Analysis: Q1, 2016 By the Numbers May 12 2016
Neurocrine Biosciences to Present at the Bank of America Merrill Lynch 2016 Health Care Conference May 10 2016
NBIX: NDA for Valbenazine in Tardive Dyskinesia to be Filed in 2016… May 09 2016
Neurocrine Biosciences Announces Additional Valbenazine (NBI-98854) Data to be Presented at the... May 06 2016
Neurocrine Biosciences to Present at the Bank of America Merrill Lynch 2016 Health Care Conference May 06 2016
Edited Transcript of NBIX earnings conference call or presentation 5-May-16 9:00pm GMT May 06 2016
Neurocrine Biosciences Reports First Quarter 2016 Results May 06 2016
Neurocrine Biosciences Announces Additional Valbenazine (NBI-98854) Data to be Presented at the... May 06 2016
Neurocrine reports 1Q loss May 05 2016
Neurocrine reports 1Q loss May 05 2016
NEUROCRINE BIOSCIENCES INC Files SEC form 8-K, Results of Operations and Financial Condition,... May 05 2016
Neurocrine Biosciences Reports First Quarter 2016 Results May 05 2016
Q1 2016 Neurocrine Biosciences Inc Earnings Release - After Market Close May 05 2016
Neurocrine Biosciences Announces Conference Call and Webcast to Report First Quarter 2016 Results Apr 29 2016
Neurocrine Biosciences Announces Conference Call and Webcast to Report First Quarter 2016 Results Apr 29 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)